
Sign up to save your podcasts
Or


China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race
See omnystudio.com/listener for privacy information.
By Bloomberg4.8
2020 ratings
China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race
See omnystudio.com/listener for privacy information.

399 Listeners

1,173 Listeners

2,178 Listeners

1,945 Listeners

426 Listeners

353 Listeners

968 Listeners

191 Listeners

58 Listeners

1,297 Listeners

66 Listeners

30 Listeners

63 Listeners

4 Listeners

157 Listeners

58 Listeners

232 Listeners

232 Listeners

60 Listeners

78 Listeners

80 Listeners

61 Listeners

82 Listeners

391 Listeners

179 Listeners

9 Listeners

17 Listeners

12 Listeners

148 Listeners

8 Listeners

2 Listeners

72 Listeners